Refractive Patient Satisfaction: Expectations for Postoperative Vision Postoperative Satisfaction

Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. Educational Objectives Ophthalmologists who participate in this activity will: • Identify the true impact of a dysfunctional ocular surface on cataract and refractive outcomes, identify the consequences that accompany an unstable tear film, and discuss the presentation of symptomatic vs. asymptomatic OSD Designation Statement The American Society of Cataract and Refractive Surgery designates this enduring materials educational activity for a maximum of 1.0 AMA PRA Category 1 Credits.TM Physicians should claim only credit commensurate with the extent of their participation in the activity. Claiming Credit To claim credit, participants must visit bit.ly/2bfDuPS to review content and download the post-activity test and credit claim. All participants must pass the post-activity test with a score of 75% or higher to earn credit. Alternatively, the post-test form included in this monograph may be faxed to the number indicated for credit to be awarded, and a certificate will be mailed within two weeks. When viewing online or downloading the material, standard internet access is required. Adobe Acrobat Reader is needed to view the materials. CME credit is valid through March 31, 2017. CME credit will not be awarded after that date. Notice of Off-Label Use Presentations This activity may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the FDA or have been approved by the FDA for specific uses only. ADA/Special Accommodations ASCRS and EyeWorld fully comply with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. Any participant in this educational program who requires special accommodations or services should contact Laura Johnson at [email protected] or 703-591-2220. Financial Interest Disclosures Marjan Farid, MD, has received a retainer, ad hoc fees or other consulting income from Abbott Medical Optics, Allergan, RPS, Shire, and TearScience. Edward Holland, MD, has received a retainer, ad hoc fees or other consulting income from: Alcon, Bausch + Lomb, Kala Pharmaceuticals, Mati Therapeutics, PRN, RPS, Senju, Shire, Tear Science, and TearLab. He is a member of the speakers bureau of: Alcon, Bausch + Lomb, Kala, Mati, RPS, Senju, and TearLab. Dr. Holland has received research funding from Alcon, Mati, PRN, and Senju, and has received travel expense reimbursement from Alcon and Bausch + Lomb. Steven Schallhorn, MD, has received a retainer, ad hoc fees, or other consulting income from Abbott Medical Optics, AcuFocus, Carl Zeiss Meditec, and Ivantis. Elizabeth Yeu, MD, has an investment interest in: Modernizing Medicine, RPS, and Strathspey Crown. She has received a retainer, ad hoc fees, or other consulting income from, and is a member of the speakers bureau of: Abbott Medical Optics, Alcon Laboratories, Allergan, Bio-Tissue, i-Optics, Ocular Therapeutix, Shire, TearLab, and Valeant. She has received a retainer, ad hoc fees, or other consulting income from: Alphaeon, GlassessOff, RPS, and TearScience. She is a member of the speakers bureau of Omeros. Staff members: Kristen Covington, Laura Johnson, and Erin Schallhorn have no ophthalmic-related financial interests. 365 Curriculum Ocular surface disease (OSD)